Drug Summary

  Drug name:  fulvestrant
  Chemical name:  ICI 182,780
  Formula:  C₃₂H₄₇F₅O_{3  Weight:   606.771
  CAS no:  129453-61-8
  DrugBank link:  DB00947
  Description:  Fulvestrant is a drug treatment of hormone receptor-positive metastatic breast cancer in post-menopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works both by down-regulating and by degrading the estrogen receptor.
  Indication:  For the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy.}